{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:15:43Z","timestamp":1785842143855,"version":"3.56.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1111\/igc.0b013e3181a29dfe","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T13:44:32Z","timestamp":1291383872000},"page":"834-837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Phase II Study of Intraperitoneal Carboplatin With Intravenous Paclitaxel in Patients With Suboptimal Residual Epithelial Ovarian or Primary Peritoneal Cancer"],"prefix":"10.1016","volume":"19","author":[{"given":"Keiichi","family":"Fujiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzo","family":"Kigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Noma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Numa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Aotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/IGC.0b013e3181a29dfe_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1525-1438.2007.00809.x","article-title":"Principles and practice of intraperitoneal chemotherapy for ovarian cancer","volume":"17","author":"Fujiwara","year":"2007","journal-title":"Int J Gynecol Cancer."},{"key":"10.1111\/IGC.0b013e3181a29dfe_bb0010","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N Engl JMed."},{"key":"10.1111\/IGC.0b013e3181a29dfe_bb0015","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.2001.19.4.1001","volume":"19","author":"Markman","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1111\/IGC.0b013e3181a29dfe_bb0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1111\/IGC.0b013e3181a29dfe_bb0025","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0090-8258(03)00377-9","article-title":"First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up","volume":"90","author":"Fujiwara","year":"2003","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a29dfe_bb0030","first-page":"4265","article-title":"Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer","volume":"42","author":"Ozols","year":"1982","journal-title":"Cancer Res."},{"key":"10.1111\/IGC.0b013e3181a29dfe_bb0035","first-page":"3495","article-title":"Flow cytometry studies of intracellular adriamycin in multicell spheroids in vitro","volume":"41","author":"Durand","year":"1981","journal-title":"Cancer Res."},{"key":"10.1111\/IGC.0b013e3181a29dfe_bb0040","first-page":"3665","article-title":"Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjuvant chemotherapy","volume":"40","author":"West","year":"1980","journal-title":"Cancer Res."},{"key":"10.1111\/IGC.0b013e3181a29dfe_bb0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF00257130","article-title":"Penetration and binding of vinblastine and 5-fluorouracil in cellular spheroids","volume":"13","author":"Nederman","year":"1984","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1111\/IGC.0b013e3181a29dfe_bb0050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.7326\/0003-4819-97-6-845","article-title":"Intraperitoneal cisplatin with systemic thiosulfate protection","volume":"97","author":"Howell","year":"1982","journal-title":"Ann Intern Med."},{"key":"10.1111\/IGC.0b013e3181a29dfe_bb0055","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ygyno.2005.06.055","volume":"99","author":"Miyagi","year":"2005","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a29dfe_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2004.12.005","article-title":"Intraperitoneal carboplatinbased chemotherapy for epithelial ovarian cancer","volume":"97","author":"Fujiwara","year":"2005","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a29dfe_bb0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00685503","article-title":"Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy","volume":"28","author":"Los","year":"1991","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1111\/IGC.0b013e3181a29dfe_bb0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/gyno.1993.1171","article-title":"Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer","volume":"50","author":"Markman","year":"1993","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a29dfe_bb0075","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1525-1438.2008.01192.x","article-title":"Combination chemotherapy of intraperitoneal carboplatin and intravenous paclitaxel in suboptimally debulked epithelial ovarian cancer","volume":"18","author":"Nagao","year":"2008","journal-title":"Int J Gynecol Cancer."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2FIGC.0b013e3181a29dfe","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24027245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24027245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:34:53Z","timestamp":1753101293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24027245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1048891X24027245"],"URL":"https:\/\/doi.org\/10.1111\/igc.0b013e3181a29dfe","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase II Study of Intraperitoneal Carboplatin With Intravenous Paclitaxel in Patients With Suboptimal Residual Epithelial Ovarian or Primary Peritoneal Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/IGC.0b013e3181a29dfe","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}